GLPwatch

Long-acting glucagon-like peptide 1 receptor agonists: a review of their efficacy and tolerability.

Diabetes Care · 2011

Last updated 2026-05-28
JournalDiabetes Care, 2011
Citations265
Relative citation ratio7.96
NIH percentile96
Molecules —
Conditions studied Type 2 Diabetes, Obesity, Cardiovascular Risk Reduction, Chronic Kidney Disease

Full record and abstract on PubMed 21525469 ↗